Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
J Alzheimers Dis ; 13(2): 225-32, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18376063

RESUMO

Oxidative stress constitutes a hallmark of Alzheimer's disease (AD). Recent studies also point to redox active metals such as iron, copper and zinc in mediating oxidative stress in AD pathogenesis. However, the reactivity of cerebrospinal fluid (CSF) iron and its possible correlation with the severity of cognitive decline in both Alzheimer's patients and subjects with mild cognitive impairment (MCI) is still unknown. Here we show that different stages of cognitive and functional impairment are associated with changes in CSF reactive iron. In this work, we compared CSF samples from 56 elders, classified into 4 groups according to their scores on the Clinical Dementia Rating scale (CDR). Total CSF iron was analyzed by atomic absorption spectrometry. Redox-active iron was analyzed by a novel fluorimetric assay. One-way ANOVA was used to test differences in mean values, and Newman-Keuls Multiple Comparison Test was used for multi group comparisons. No difference in total CSF iron was found between different groups. Significant amounts of redox-active iron were found in CSF and their levels correlated with the extent of cognitive impairment. Redox-active CSF iron levels increased with the degree of cognitive impairment from normal to MCI subjects, while AD patients showed an abrupt decrease to levels close to zero. Given the relevance of oxidative damage in neurodegeneration, it might be possible to associate the development of cognitive and functional decline with the presence of redox-active iron in the CSF. The decrease in redox-active iron found in AD patients may represent a terminal situation, whereby the central nervous system attempts to minimize iron-associated toxicity.


Assuntos
Doença de Alzheimer , Transtornos Cognitivos/diagnóstico , Ferro/líquido cefalorraquidiano , Idoso , Doença de Alzheimer/líquido cefalorraquidiano , Doença de Alzheimer/diagnóstico , Doença de Alzheimer/fisiopatologia , Feminino , Humanos , Masculino , Oxirredução , Índice de Gravidade de Doença , Inquéritos e Questionários
2.
Rev. Méd. Clín. Condes ; 15(4): 146-154, oct. 2004. ilus, tab, graf
Artigo em Espanhol | LILACS | ID: lil-425104

RESUMO

El Síndrome de Piernas Inquietas (SPI) se caracteriza por una sensación desagradable en las piernas que lleva a la imperiosa necesidad de moverlas. Ocurre en reposo y es de preferencia nocturna. Su frecuencia varía entre 2-15 por ciento de la población general adulta y 20-30 por ciento en pacientes urémicos en diálisis. A nivel nacional se da una frecuencia estimativa de 13 por ciento en la población general adulta y 27 por ciento en los pacientes urémicos en diálisis.


Assuntos
Adulto , Humanos , Criança , Síndrome das Pernas Inquietas/diagnóstico , Síndrome das Pernas Inquietas/etiologia , Síndrome das Pernas Inquietas/terapia , Dopaminérgicos/administração & dosagem , Dopaminérgicos/efeitos adversos , Antagonistas de Dopamina/efeitos adversos , Diagnóstico Diferencial , Dopamina/biossíntese , Ferro/deficiência , Ferro/líquido cefalorraquidiano , Ferro/uso terapêutico , Polissonografia , Síndrome das Pernas Inquietas/epidemiologia , Uremia/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA